跳至主要内容
临床试验/CTRI/2012/05/002670
CTRI/2012/05/002670已完成3 期

A Randomized, Prospective, Double Blind, Placebo Controlled Study to Evaluate Efficacyand Safety of KSM-66 Ashwagandha (Withania somnifera) on Improving CardioRespiratory Endurance in Healthy Athletic Adults

SKP Labs Private Limited0 个研究点目标入组 50 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Healthy athletic adults of male and female subjects aged
  • between 20 and 45 years.
  • 2. Subjects within the BMI range of 18.5 to 24.9 kg/m2
  • 3. Subjects able to communicate effectively
  • 4. Subjects willing to provide written informed consent
  • 5. In the judgment of the Principal Investigator, able to
  • comply with protocol requirements

排除标准

  • 1 Contraindications or Hypersensitivity to ashwagandha and
  • related herbal products.
  • 2 History or presence of any medical condition or disease
  • according to the discretion of the Investigator.
  • 3 History of significant renal or hepatic problems.
  • 4 History of significant asthma, urticaria or other allergic
  • 5 History of severe GI disorders such as mal-absorption
  • 6 History of diabetes, coronary artery disease and hypertension
  • with or without complication
  • 7 History of any chronic physical, hormonal or psychiatric
  • 8 Morbid Obesity (percent fat 40%
  • 9 Any medical condition where exercise is contraindicated
  • 10 Recent surgery or trauma which incapacitates the subject for
  • 11 Currently taking any herbal preparations (other formulations
  • containing ashwagandha / ginseng / ginkgo biloba / brahmi
  • 12 Current substance dependence
  • 13 Individuals refusing to use appropriate non-hormonal birth
  • control measures.
  • 14 Subjects participating in any other trial.
  • 15 Female subjects found positive in urine pregnancy test.
  • 16 Female subjects who are under breast feeding.

研究者

发起方
SKP Labs Private Limited

相似试验